Evidence map›Paper›PMID 29047406›Full record

ArticleSkeletal muscle2017

Loss of MKP-5 promotes myofiber survival by activating STAT3/Bcl-2 signaling during regenerative myogenesis.

Kisuk Min, Ahmed Lawan, Anton M Bennett

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Mitochondrial stress response and myogenic differentiation.Frontiers in cell and developmental biology · 2024
    Review
  3. Mitochondrial dysfunction: roles in skeletal muscle atrophy.Journal of translational medicine · 2023
    Review
  4. Article
  5. Skeletal Muscle Regeneration in Cardiotoxin-Induced Muscle Injury Models.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Article
  8. Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2019
    Article
  9. Article
  10. Dual-specificity MAP kinase phosphatases in health and disease.Biochimica et biophysica acta. Molecular cell research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kisuk MinDepartment of Pharmacology, Yale University, New Haven, CT, 06520, USA.
Ahmed LawanDepartment of Pharmacology, Yale University, New Haven, CT, 06520, USA.
Anton M BennettDepartment of Pharmacology, Yale University, New Haven, CT, 06520, USA. anton.bennett@yale.edu.
Yale University · US

Funding

MKP5 in Dystrophic Muscle DiseaseR01AR066003 · NIAMS · YALE UNIVERSITY · PI BENNETT, ANTON M · 2015 to 2019
$2.0M
NIAMS NIH HHS R01 AR066003
6 · The paper itself

Abstract

backgroundThe mitogen-activated protein kinases (MAPKs) have been shown to be involved in regulating myofiber survival. In skeletal muscle, p38 MAPK and JNK are negatively regulated by MAPK phosphatase-5 (MKP-5). During muscle regeneration, MKP-5 is downregulated, thereby promoting p38 MAPK/JNK signaling, and subsequent repair of damaged muscle. Mice lacking MKP-5 expression exhibit enhanced regenerative myogenesis. However, the effect of MKP-5 on myofiber survival during regeneration is unclear.

methodsTo investigate whether MKP-5 is involved in myofiber survival, skeletal muscle injury was induced by cardiotoxin injection, and the effects on apoptosis were assessed by TUNEL assay in wild type and MKP-5-deficient mice. The contribution of MKP-5 to apoptotic signaling and its link to this pathway through mitochondrial function were determined in regenerating skeletal muscle of MKP-5-deficient mice.

resultsWe found that loss of MKP-5 in skeletal muscle resulted in improved myofiber survival. In response to skeletal muscle injury, loss of MKP-5 decreased activation of the mitochondrial apoptotic pathway involving the signal transducer and activator of transcription 3 (STAT3) and increased expression of the anti-apoptotic transcription factor Bcl-2. Skeletal muscle of MKP-5-deficient mice also exhibited an improved anti-oxidant capacity as a result of increased expression of catalase further contributing to myofiber survival by attenuating oxidative damage.

conclusionsTaken together, these findings suggest that MKP-5 coordinates skeletal muscle regeneration by regulating mitochondria-mediated apoptosis. MKP-5 negatively regulates apoptotic signaling, and during regeneration, MKP-5 downregulation contributes to the restoration of myofiber survival. Finally, these results suggest that MKP-5 inhibition may serve as an important therapeutic target for the preservation of skeletal muscle survival in degenerative muscle diseases.

Indexed as

ApoptosisMuscle DevelopmentSignal TransductionAnimalsCell LineDual-Specificity PhosphatasesMiceMice, Inbred C57BLMuscle Fibers, SkeletalProto-Oncogene Proteins c-bcl-2RegenerationSTAT3 Transcription FactorBcl2 protein, mouseDual-Specificity PhosphatasesDusp10 protein, mouseProto-Oncogene Proteins c-bcl-2Stat3 protein, mouseSTAT3 Transcription FactorBcl-2MAP kinaseMitochondriaMKP-5Myonuclear apoptosisReactive oxygen speciesRegenerationSTAT3

Identifiers

PMID29047406
PMCPMC5648478
OpenAlexW2765901909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.